The Effect of Fibrinogen Genotype on Fibrinogen Levels after Strenuous Physical Exercise

Summary

We have examined the effect of two f3-fibrinogen gene promoter polymorphisms (-455G>A and -854G>A) on the fibrinogen response to severe exercise in a group of male army recruits undergoing basic training. Fibrinogen was measured pre-training and again serially after severe 48 h final military exercise (FME). Out of 884 subjects, 762 completed training of whom 250 were selected for post-FME study. Fibrinogen levels (g/l) were significantly elevated over baseline levels 2, 48 and 96 h after FME, representing increases of 15.7%, 3.4% and 7.6% (p <0.005; p = 0.05 and p <0.005 respectively), with higher levels in -455A allele carriers than genotype -455GG: 3.17 ± 0.05 vs. 2.94 ± 0.05 (p <0.001), 2.86 ± 0.05 vs. 2.60 ± 0.05 (p <0.0005) and 2.98 ± 0.06 vs. 2.69 ± 0.06 (p <0.0005) at 2, 48 and 96 h respectively. There was no effect of the -854G>A polymorphism on fibrinogen, even after taking into account f3-fibrinogen -455 genotype. Thus the fibrinogen -455G>A polymorphism influences fibrinogen levels following exercise. The effect of genotype might be clinically relevant at times of hyperfibrinogenaemia such as following an acute inflammatory response.

Keywords

Fibrinogen - genetics - exercise

• References

• 1 Green F, Humphries S. Control of plasma fibrinogen levels. Ballieres Clin Haematol 1989; 02: 945-59.
• 2 de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 1996; 121 (02) 185-91.
• 3 Kvasnicka J, Briza J, Krska Z, Kudrna K, Peskova M, Pecen L. Increase of soluble cytoadhesive molecules sE-selectin and sICAM-1 and hyperfibrinogenaemia in patients with polytrauma without septicaemia. Sb Lek 1998; 99 (02) 93-6.
• 4 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR. et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02 8506 533-7.
• 5 Kannel WB, Wolf PA, Catelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease The Framingham Study. JAMA 1987; 258: 1183-6.
• 6 Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ. et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83 (03) 836-44.
• 7 Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease FRISC Study Group Fragmin during Instability in Coronary Artery Disease. Circulation 1997; 96 (12) 4204-10.
• 8 Shah P, Chander R, Daly K. Plasma fibrinogen level and other risk factor profile; association with coronary artery disease. Br Heart J 1995; 71 (05) P25.
• 9 Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332 (10) 635-41.
• 10 Fowkes FG, Pell JP, Donnan PT, Housley E, Lowe GD, Riemersma RA. et al. Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis Importance of plasma fibrinogen and blood viscosity. Arterioscler Thromb 1994; 14 (06) 862-8.
• 11 Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Eng J Med 1984; 311: 501-5.
• 12 Ernst E. Regular exercise reduces fibrinogen levels: a review of longitudinal studies. Br J Sports Med 1993; 27 (03) 175-6.
• 13 Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-63.
• 14 Woodward M, Lowe GD, Rumley A, Tunstall-Pedoe H. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women The Scottish Heart Health Study. Eur Heart J 1998; 19 (01) 55-62.
• 15 Castell LM, Poortmans JR, Leclercq R, Brasseur M, Duchateau J, Newholme EA. Some aspects of the acute phase response after a marathon race, and the effects of glutamine supplementation. Eur J Appl Physiol 1997; 75 (01) 47-53.
• 16 Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000; 80 (03) 1055-81.
• 17 Sprenger H, Jacobs C, Nain M, Gressner AM, Prinz H, Wesemann W. et al. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol 1992; 63 (02) 188-95.
• 18 Camus G, Poortmans J, Nys M, Deby-Dupont G, Duchateau J, Deby C. et al. Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin Sci (Colch 1997; 92 (04) 415-22.
• 19 Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro-and antiinflammatory cytokine balance in strenuous exercise in humans. J Physiol (Lond) 1999; 515 (Pt 1) 287-91.
• 20 Keber D, Stegnar M, Keber I, Accetto B. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost 1979; 41: 745-55.
• 21 Dufaux B, Order U, Hollman W. Can exercise induce an effective fibrinolysis?. Thromb Res 1984; 36: 37-43.
• 22 Arai M, Yorifuji H, Ikematsu S, Nagaswa H, Fujimaki M, Fukutake K. et al. Influences of strenuous exercise (triathalon) on blood coagulation and fibrinolytic system. Thrombosis Res 1990; 57 (03) 465-71.
• 23 Weight LM, Alexander D, Jacobs P. Strenuous exercise: analogous to the acute-phase response?. Clin Sci (Colch 1991; 81 (05) 677-83.
• 24 Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C. et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioscler Thromb Vasc Biol 1996; 16 (03) 386-91.
• 25 Ernst E. Some basic facts about fibrinogen – an introduction. In: In: Ernst E, Koenig W, Lowe GDO, Meade TW. Fibrinogen: a “new” cardiovascular risk factor. Blackwell-MSV; 1992
• 26 Marino MW, Fuller GM, Elder FF. Chromosomal localization of human and rat A alpha, B beta, and gamma fibrinogen genes by in situ hybridization. Cytogenet Cell Genet 1986; 42 1-2 36-41.
• 27 Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly: transfection of hep G2 cells with f3-cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265 (11) 6389-93.
• 28 Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promotor contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993; 13 (02) 1183-93.
• 29 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW. et al. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65 (05) 487-90.
• 30 Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D. et al. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction The ECTIM Study. Arterioscler Thromb 1993; 13 (06) 886-91.
• 31 Green F, Hamsten A, Blomback M, Humphries S. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70 (06) 915-20.
• 32 Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15 (01) 96-104.
• 33 Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E. et al. Impact of polymorphisms in the alpha and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995; 77 (03) 209-15.
• 34 Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G-455 → A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997; 99 (12) 3034-9.
• 35 Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet 1994; 94 (02) 165-70.
• 36 Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G. et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction The ECTIM Study Etude Cas-Temoins sur l’Infarctus du Myocarde. Circulation 1996; 93 (03) 440-9.
• 37 Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum Mutat 1994; 03 (01) 79-81.
• 38 van ’t FMHooft, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999; 19 (12) 3063-70.
• 39 Cotton JM, Webb KE, Mathur A, Martin JF, Humphries SE. Impact of the -455G>A promoter polymorphism in the B fibrinogen gene on stimulated fibrinogen production following bypass surgery. Thromb Haemost 2000; 84 (05) 926-7.
• 40 Gardemann A, Schwartz O, Haberbosch W, Katz N, Weiss T, Tillmanns H. et al. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost 1997; 77 (06) 1120-6.
• 41 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acid Res 1988; 16: 1215-6.
• 42 Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet 1984; 36 (06) 1239-58.
• 43 Paffenbarger RS, Hyde RT, Wing AL, Hsieh C. Physical activity, all-cause mortality, and longevity of college alumni. New Eng J Med 1986; 314: 605-13.
• 44 Lakka TA, Salonen JT. Moderate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish men. J Clin Epidemiol 1993; 46 (10) 1119-27.
• 45 Bettega D, Zanettini R, Ferretti M. [Physical training exercise reduces the plasma levels of fibrinogen in subjects with mild hypertension]. Ann Ital Med Int 1995; 10 (03) 167-70.
• 46 Assanelli D, Bersatti F, Ferrari R, Bollani G, Ferrari M, Ballardini E. et al. Effect of leisure time and working activity on principal risk factors and relative interactions in active middle-aged men. Coron Artery Dis 1999; 10 (01) 1-7.
• 47 Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96 (01) 168-73.
• 48 Zito F, Di Castelnuovo A, D’Orazio A, Negrini R, De Lucia D, Donati MB. et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999; 82 (01) 14-8.